CA2289627A1 - An implant element - Google Patents
An implant element Download PDFInfo
- Publication number
- CA2289627A1 CA2289627A1 CA002289627A CA2289627A CA2289627A1 CA 2289627 A1 CA2289627 A1 CA 2289627A1 CA 002289627 A CA002289627 A CA 002289627A CA 2289627 A CA2289627 A CA 2289627A CA 2289627 A1 CA2289627 A1 CA 2289627A1
- Authority
- CA
- Canada
- Prior art keywords
- titanium
- bone
- implants
- implant
- electropolished
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000007943 implant Substances 0.000 title claims abstract description 255
- 239000010936 titanium Substances 0.000 claims abstract description 114
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 110
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 108
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 108
- 210000001519 tissue Anatomy 0.000 claims abstract description 42
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 27
- 238000002513 implantation Methods 0.000 claims abstract description 10
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000002048 anodisation reaction Methods 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 34
- 230000008569 process Effects 0.000 claims description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 5
- 229960002163 hydrogen peroxide Drugs 0.000 claims 1
- 210000004027 cell Anatomy 0.000 description 51
- 239000000463 material Substances 0.000 description 36
- 102000004169 proteins and genes Human genes 0.000 description 33
- 108090000623 proteins and genes Proteins 0.000 description 33
- 230000004044 response Effects 0.000 description 31
- 238000001179 sorption measurement Methods 0.000 description 27
- 229910052751 metal Inorganic materials 0.000 description 26
- 239000002184 metal Substances 0.000 description 26
- 210000004872 soft tissue Anatomy 0.000 description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 239000010410 layer Substances 0.000 description 20
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 19
- 238000000338 in vitro Methods 0.000 description 18
- 241000700159 Rattus Species 0.000 description 17
- 239000011780 sodium chloride Substances 0.000 description 17
- 239000011575 calcium Substances 0.000 description 16
- 239000000203 mixture Substances 0.000 description 16
- 229910052791 calcium Inorganic materials 0.000 description 15
- 238000012876 topography Methods 0.000 description 15
- 210000002540 macrophage Anatomy 0.000 description 14
- 230000004048 modification Effects 0.000 description 14
- 238000012986 modification Methods 0.000 description 14
- 150000003608 titanium Chemical class 0.000 description 14
- 238000001727 in vivo Methods 0.000 description 13
- 239000002775 capsule Substances 0.000 description 12
- 210000000963 osteoblast Anatomy 0.000 description 12
- 239000000523 sample Substances 0.000 description 12
- 230000003746 surface roughness Effects 0.000 description 12
- 229910052799 carbon Inorganic materials 0.000 description 11
- 230000003993 interaction Effects 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 239000012981 Hank's balanced salt solution Substances 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 10
- 150000002739 metals Chemical class 0.000 description 10
- 108010088751 Albumins Proteins 0.000 description 9
- 102000009027 Albumins Human genes 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000033558 biomineral tissue development Effects 0.000 description 9
- 230000001413 cellular effect Effects 0.000 description 9
- 239000012530 fluid Substances 0.000 description 9
- 238000003754 machining Methods 0.000 description 9
- 229910052760 oxygen Inorganic materials 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 8
- 108010049003 Fibrinogen Proteins 0.000 description 8
- 102000008946 Fibrinogen Human genes 0.000 description 8
- 108010067306 Fibronectins Proteins 0.000 description 8
- 102000016359 Fibronectins Human genes 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 210000000416 exudates and transudate Anatomy 0.000 description 8
- 229940012952 fibrinogen Drugs 0.000 description 8
- 238000010883 osseointegration Methods 0.000 description 8
- 230000011164 ossification Effects 0.000 description 8
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 229910052717 sulfur Inorganic materials 0.000 description 7
- -1 while TizO Inorganic materials 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 230000001054 cortical effect Effects 0.000 description 6
- 230000004069 differentiation Effects 0.000 description 6
- 210000002950 fibroblast Anatomy 0.000 description 6
- 230000002757 inflammatory effect Effects 0.000 description 6
- 230000007774 longterm Effects 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 238000001356 surgical procedure Methods 0.000 description 6
- 102000004506 Blood Proteins Human genes 0.000 description 5
- 108010017384 Blood Proteins Proteins 0.000 description 5
- 102000012422 Collagen Type I Human genes 0.000 description 5
- 108010022452 Collagen Type I Proteins 0.000 description 5
- 206010061218 Inflammation Diseases 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 239000012620 biological material Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 230000035876 healing Effects 0.000 description 5
- 229940027941 immunoglobulin g Drugs 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 238000013425 morphometry Methods 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 239000010935 stainless steel Substances 0.000 description 5
- 229910001220 stainless steel Inorganic materials 0.000 description 5
- 239000002344 surface layer Substances 0.000 description 5
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 238000004833 X-ray photoelectron spectroscopy Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000004053 dental implant Substances 0.000 description 4
- NZZFYRREKKOMAT-UHFFFAOYSA-N diiodomethane Chemical compound ICI NZZFYRREKKOMAT-UHFFFAOYSA-N 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 208000007565 gingivitis Diseases 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 210000004969 inflammatory cell Anatomy 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 229910052710 silicon Inorganic materials 0.000 description 4
- 238000001228 spectrum Methods 0.000 description 4
- 230000007480 spreading Effects 0.000 description 4
- 238000003892 spreading Methods 0.000 description 4
- 210000002303 tibia Anatomy 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 102000004264 Osteopontin Human genes 0.000 description 3
- 108010081689 Osteopontin Proteins 0.000 description 3
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 230000008512 biological response Effects 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 238000005530 etching Methods 0.000 description 3
- 210000002744 extracellular matrix Anatomy 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 230000005661 hydrophobic surface Effects 0.000 description 3
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 210000005087 mononuclear cell Anatomy 0.000 description 3
- 230000000877 morphologic effect Effects 0.000 description 3
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 3
- WEXRUCMBJFQVBZ-UHFFFAOYSA-N pentobarbital Chemical compound CCCC(C)C1(CC)C(=O)NC(=O)NC1=O WEXRUCMBJFQVBZ-UHFFFAOYSA-N 0.000 description 3
- 230000007115 recruitment Effects 0.000 description 3
- 238000012552 review Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- 208000006386 Bone Resorption Diseases 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 241000283707 Capra Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 229910000771 Vitallium Inorganic materials 0.000 description 2
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 2
- 210000003815 abdominal wall Anatomy 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 230000006978 adaptation Effects 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000010407 anodic oxide Substances 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000002917 arthritic effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000018678 bone mineralization Effects 0.000 description 2
- 230000024279 bone resorption Effects 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000006041 cell recruitment Effects 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 238000007385 chemical modification Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 210000001612 chondrocyte Anatomy 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229940096422 collagen type i Drugs 0.000 description 2
- RKTYLMNFRDHKIL-UHFFFAOYSA-N copper;5,10,15,20-tetraphenylporphyrin-22,24-diide Chemical group [Cu+2].C1=CC(C(=C2C=CC([N-]2)=C(C=2C=CC=CC=2)C=2C=CC(N=2)=C(C=2C=CC=CC=2)C2=CC=C3[N-]2)C=2C=CC=CC=2)=NC1=C3C1=CC=CC=C1 RKTYLMNFRDHKIL-UHFFFAOYSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical compound N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000005538 encapsulation Methods 0.000 description 2
- 210000002919 epithelial cell Anatomy 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000005660 hydrophilic surface Effects 0.000 description 2
- 230000002055 immunohistochemical effect Effects 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 210000004373 mandible Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 210000004379 membrane Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000003562 morphometric effect Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 210000004409 osteocyte Anatomy 0.000 description 2
- 229960001412 pentobarbital Drugs 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 238000002203 pretreatment Methods 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- 238000012453 sprague-dawley rat model Methods 0.000 description 2
- 238000004544 sputter deposition Methods 0.000 description 2
- 238000004381 surface treatment Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000009885 systemic effect Effects 0.000 description 2
- 238000004506 ultrasonic cleaning Methods 0.000 description 2
- 239000000602 vitallium Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229910052726 zirconium Inorganic materials 0.000 description 2
- AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 238000000035 BCA protein assay Methods 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 1
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 1
- 102000001187 Collagen Type III Human genes 0.000 description 1
- 108010069502 Collagen Type III Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000283074 Equus asinus Species 0.000 description 1
- 229910001200 Ferrotitanium Inorganic materials 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical group CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 208000029725 Metabolic bone disease Diseases 0.000 description 1
- 206010029260 Neuroblastoma Diseases 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 108090000573 Osteocalcin Proteins 0.000 description 1
- 206010049088 Osteopenia Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 208000006735 Periostitis Diseases 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 102000016611 Proteoglycans Human genes 0.000 description 1
- 108010067787 Proteoglycans Proteins 0.000 description 1
- 102000002085 Prothrombin/thrombin Human genes 0.000 description 1
- 108050009405 Prothrombin/thrombin Proteins 0.000 description 1
- 101000930457 Rattus norvegicus Albumin Proteins 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 239000006180 TBST buffer Substances 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 239000007976 Tris-NaCl-Tween buffer Substances 0.000 description 1
- COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
- 229940117913 acrylamide Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 238000000089 atomic force micrograph Methods 0.000 description 1
- 238000004630 atomic force microscopy Methods 0.000 description 1
- 210000001142 back Anatomy 0.000 description 1
- 210000004082 barrier epithelial cell Anatomy 0.000 description 1
- HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000011748 cell maturation Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000012505 colouration Methods 0.000 description 1
- 238000003271 compound fluorescence assay Methods 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 229960003529 diazepam Drugs 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000002224 dissection Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 230000009881 electrostatic interaction Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000004890 epithelial barrier function Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229950003499 fibrin Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004195 gingiva Anatomy 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002343 gold Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000000925 high-voltage transmission electron microscopy Methods 0.000 description 1
- 230000002962 histologic effect Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000010874 in vitro model Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000004941 influx Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000010849 ion bombardment Methods 0.000 description 1
- 210000001847 jaw Anatomy 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 210000002050 maxilla Anatomy 0.000 description 1
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 238000007491 morphometric analysis Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000000663 muscle cell Anatomy 0.000 description 1
- 239000010955 niobium Substances 0.000 description 1
- 229910052758 niobium Inorganic materials 0.000 description 1
- GUCVJGMIXFAOAE-UHFFFAOYSA-N niobium atom Chemical compound [Nb] GUCVJGMIXFAOAE-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- SOQBVABWOPYFQZ-UHFFFAOYSA-N oxygen(2-);titanium(4+) Chemical class [O-2].[O-2].[Ti+4] SOQBVABWOPYFQZ-UHFFFAOYSA-N 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000003239 periodontal effect Effects 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- INAAIJLSXJJHOZ-UHFFFAOYSA-N pibenzimol Chemical compound C1CN(C)CCN1C1=CC=C(N=C(N2)C=3C=C4NC(=NC4=CC=3)C=3C=CC(O)=CC=3)C2=C1 INAAIJLSXJJHOZ-UHFFFAOYSA-N 0.000 description 1
- 238000007750 plasma spraying Methods 0.000 description 1
- 210000004180 plasmocyte Anatomy 0.000 description 1
- 239000000088 plastic resin Substances 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000007586 pull-out test Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 238000001275 scanning Auger electron spectroscopy Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000000682 scanning probe acoustic microscopy Methods 0.000 description 1
- 230000036573 scar formation Effects 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000013545 self-assembled monolayer Substances 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- HBMJWWWQQXIZIP-UHFFFAOYSA-N silicon carbide Chemical compound [Si+]#[C-] HBMJWWWQQXIZIP-UHFFFAOYSA-N 0.000 description 1
- 229910010271 silicon carbide Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- UCPVOMHRDXMAIZ-UHFFFAOYSA-M sodium acetrizoate Chemical compound [Na+].CC(=O)NC1=C(I)C=C(I)C(C([O-])=O)=C1I UCPVOMHRDXMAIZ-UHFFFAOYSA-M 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- ILXAOQAXSHVHTM-UHFFFAOYSA-M sodium;2-amino-2-(hydroxymethyl)propane-1,3-diol;chloride Chemical compound [Na+].[Cl-].OCC(N)(CO)CO ILXAOQAXSHVHTM-UHFFFAOYSA-M 0.000 description 1
- 238000002336 sorption--desorption measurement Methods 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 238000004627 transmission electron microscopy Methods 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 238000010246 ultrastructural analysis Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- LEONUFNNVUYDNQ-UHFFFAOYSA-N vanadium atom Chemical compound [V] LEONUFNNVUYDNQ-UHFFFAOYSA-N 0.000 description 1
- 238000009834 vaporization Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0012—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy
- A61C8/0013—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating
- A61C8/0015—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the material or composition, e.g. ceramics, surface layer, metal alloy with a surface layer, coating being a conversion layer, e.g. oxide layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61C—DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
- A61C8/00—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools
- A61C8/0018—Means to be fixed to the jaw-bone for consolidating natural teeth or for fixing dental prostheses thereon; Dental implants; Implanting tools characterised by the shape
- A61C8/0037—Details of the shape
- A61C2008/0046—Textured surface, e.g. roughness, microstructure
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ceramic Engineering (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dentistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9701872A SE513481C2 (sv) | 1997-05-16 | 1997-05-16 | Implantatelement utfört av titan med en titanoxidyta modifierad med eloxidering |
| SE9701872-5 | 1997-05-16 | ||
| PCT/SE1998/000891 WO1998051231A1 (en) | 1997-05-16 | 1998-05-14 | An implant element |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2289627A1 true CA2289627A1 (en) | 1998-11-19 |
Family
ID=20407006
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002289627A Abandoned CA2289627A1 (en) | 1997-05-16 | 1998-05-14 | An implant element |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6689170B1 (enExample) |
| EP (1) | EP0984735A1 (enExample) |
| JP (1) | JP2002511782A (enExample) |
| AU (1) | AU751472B2 (enExample) |
| CA (1) | CA2289627A1 (enExample) |
| SE (1) | SE513481C2 (enExample) |
| WO (1) | WO1998051231A1 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE514202C2 (sv) * | 1999-05-31 | 2001-01-22 | Nobel Biocare Ab | På implantat till ben- eller vävnadsstruktur anordnat skikt samt sådant implantat och förfarande för applicering av skiktet |
| SE514323C2 (sv) * | 1999-05-31 | 2001-02-12 | Nobel Biocare Ab | Implantat samt förfarande och användning vid implantat |
| SE516282C2 (sv) * | 2000-04-04 | 2001-12-10 | Nobel Biocare Ab | Implantat försett med anslutnings- och hålisättningsdelar samt förfarande vid dylikt implantat |
| US7048541B2 (en) * | 2000-04-04 | 2006-05-23 | Nobel Biocare Ab | Implant having attachment and hole-insert parts, and method for producing such an implant |
| SE519566C2 (sv) * | 2001-07-04 | 2003-03-11 | Nobel Biocare Ab | Förfarande för behandling av implantat genom beläggning med kalciumfosfat och bentillväxtstimulerande medel |
| SE520756C2 (sv) | 2001-12-21 | 2003-08-19 | Nobel Biocare Ab | Förfarande för att åstadkomma ytstruktur på implantat samt sådant implantat |
| GB0208642D0 (en) | 2002-04-16 | 2002-05-22 | Accentus Plc | Metal implants |
| DE50202547D1 (de) * | 2002-07-24 | 2005-04-28 | Zimmer Gmbh Winterthur | Verfahren zur Herstellung eines Implantats und Verfahren zum Dekontaminieren einer mit Strahlpartikeln behandelten Oberfläche |
| KR101095909B1 (ko) * | 2003-01-10 | 2011-12-21 | 오사카 야킨 고교 가부시키가이샤 | 생체뼈 유도성의 인공뼈와 그 제조방법 |
| GB0304168D0 (en) * | 2003-02-24 | 2003-03-26 | Benoist Girard Sas | Surface treatment of metal |
| AU2004224772B2 (en) * | 2003-03-26 | 2009-09-10 | Celonova Biosciences Germany Gmbh | Coated dental implants |
| US7008452B2 (en) * | 2003-06-26 | 2006-03-07 | Depuy Acromed, Inc. | Dual durometer elastomer artificial disc |
| GB0405680D0 (en) * | 2004-03-13 | 2004-04-21 | Accentus Plc | Metal implants |
| SE527610C2 (sv) | 2004-06-15 | 2006-04-25 | Promimic Ab | Förfarande för framställning av syntetiskt, kristallint kalciumfosfat i nanostorlek |
| SE0403020D0 (sv) * | 2004-12-13 | 2004-12-13 | Rickard Braanemark | Implantat |
| JP2006275667A (ja) * | 2005-03-28 | 2006-10-12 | Iwate Univ | 生体用金属に対する血清タンパク質複合体形成の評価方法 |
| US9327056B2 (en) | 2006-02-14 | 2016-05-03 | Washington State University | Bone replacement materials |
| JPWO2007108450A1 (ja) * | 2006-03-20 | 2009-08-06 | 独立行政法人物質・材料研究機構 | 医療用生分解性デバイスの分解時間制御方法 |
| WO2007124511A2 (en) * | 2006-04-25 | 2007-11-01 | Washington State University | Resorbable ceramics with controlled strength loss rates |
| US8916198B2 (en) * | 2006-04-25 | 2014-12-23 | Washington State University | Mesoporous calcium silicate compositions and methods for synthesis of mesoporous calcium silicate for controlled release of bioactive agents |
| DE102006021968B4 (de) * | 2006-05-04 | 2013-08-22 | Eberhard-Karls-Universität Tübingen | Enossales Implantat mit Anatasbeschichtung und Verfahren zur Herstellung |
| EP2026852B1 (en) * | 2006-06-12 | 2011-01-12 | Accentus Medical plc | Metal implants |
| EP1911412B1 (en) * | 2006-10-11 | 2011-04-13 | Astra Tech AB | Implant |
| ATE518552T1 (de) * | 2006-11-15 | 2011-08-15 | Impliant Ltd | Pedikelschrauben-oberflächenbehandlung zur verbesserung der schnittstelle zwischen knochen und implantat |
| CA2670762C (en) * | 2007-01-15 | 2015-03-31 | Accentus Plc | Metal implant coated with a metal deposited by powder plasma spraying and incorporating a biocidal metal therein |
| SE531319C2 (sv) | 2007-02-22 | 2009-02-24 | Tigran Technologies Ab Publ | Porös implantatgranul |
| SE531318C2 (sv) * | 2007-02-22 | 2009-02-24 | Tigran Technologies Ab Publ | Injicerbar suspension innefattande titan-,titanlegerings- eller titanoxidpartiklar av mikrostruktur |
| ES2310129B1 (es) * | 2007-06-01 | 2009-10-02 | Juan Carlos Garcia Saban | Nueva superficie de implantes metalicos a base de titanio destinados a ser insertado en tejido oseo. |
| ES2310978B1 (es) * | 2007-07-12 | 2009-10-20 | Francisco J. GARCIA SABAN | Implante dental roscado. |
| ES2315194B1 (es) * | 2007-09-10 | 2010-02-26 | Francisco J. GARCIA SABAN | Procedimiento para obtener una nueva superficie de un implante metalico a base de titanio destinado a ser insertado en tejido oseo. |
| US8858775B2 (en) | 2007-10-03 | 2014-10-14 | Accentus Medical Limited | Method of manufacturing metal with biocidal properties |
| SE532685C2 (sv) * | 2007-11-06 | 2010-03-16 | Tigran Technologies Ab Publ | Korn eller granuler för behandling av en skadad kota |
| US8641418B2 (en) | 2010-03-29 | 2014-02-04 | Biomet 3I, Llc | Titanium nano-scale etching on an implant surface |
| CN104870027B (zh) * | 2012-03-02 | 2018-01-19 | 新特斯有限责任公司 | 阳极化的钛装置以及相关方法 |
| US9131995B2 (en) | 2012-03-20 | 2015-09-15 | Biomet 3I, Llc | Surface treatment for an implant surface |
| ITPR20130068A1 (it) * | 2013-09-13 | 2015-03-14 | Borrozzino Carlo | Metodo per la preparazione di superfici di dispositivi di titanio-ceramica-zirconia impiantabili nel corpo umano o animale, avente risultato di rugosita' nanometrica, formazione di biossido di titanio superficiale autoindotto, elevata pulizia anti me |
| AT514320B1 (de) * | 2013-11-20 | 2014-12-15 | Steger Heinrich | Scanbody |
| US10251730B2 (en) | 2014-02-21 | 2019-04-09 | Implant And Tissue Engineering Dental Network-Tokyo, Limited Co | Implant body |
| CN113015501B (zh) * | 2018-11-12 | 2023-12-01 | 诺贝尔生物服务公司 | 牙科植入物、用于牙科应用的部件和植入物系统 |
| TWI736433B (zh) * | 2020-09-26 | 2021-08-11 | 羅政立 | 晶體取向結構鈦合金牙科植體及其製造方法 |
| WO2025189125A1 (en) * | 2024-03-07 | 2025-09-12 | University Of Mississippi Medical Center | Anodization of implant materials |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB676179A (en) | 1950-10-24 | 1952-07-23 | Michael Bernard Prichard | Improvements in ornamented lampshades |
| US5152993A (en) * | 1988-01-20 | 1992-10-06 | Ellem Bioteknik Ab | Method of preparing an implant body for implantation |
| HU213001B (en) * | 1992-04-10 | 1997-01-28 | Tavkoezlesi Innovacios Rt | Process for obtaining tissue-protective deposit on implants prepared from titanium and/or titanium-base microalloy |
| DE4407993C2 (de) * | 1994-03-10 | 1999-05-06 | Friatec Ag | Dentalimplantat |
-
1997
- 1997-05-16 SE SE9701872A patent/SE513481C2/sv not_active IP Right Cessation
-
1998
- 1998-05-14 US US09/423,250 patent/US6689170B1/en not_active Expired - Fee Related
- 1998-05-14 WO PCT/SE1998/000891 patent/WO1998051231A1/en not_active Ceased
- 1998-05-14 JP JP54914998A patent/JP2002511782A/ja not_active Ceased
- 1998-05-14 AU AU74642/98A patent/AU751472B2/en not_active Ceased
- 1998-05-14 EP EP98922004A patent/EP0984735A1/en not_active Withdrawn
- 1998-05-14 CA CA002289627A patent/CA2289627A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0984735A1 (en) | 2000-03-15 |
| US6689170B1 (en) | 2004-02-10 |
| SE513481C2 (sv) | 2000-09-18 |
| JP2002511782A (ja) | 2002-04-16 |
| SE9701872D0 (sv) | 1997-05-16 |
| SE9701872L (sv) | 1999-01-07 |
| WO1998051231A1 (en) | 1998-11-19 |
| AU751472B2 (en) | 2002-08-15 |
| AU7464298A (en) | 1998-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6689170B1 (en) | Implant element | |
| Albrektsson et al. | The interface zone of inorganic implants in vivo: titanium implants in bone | |
| Schliephake et al. | Metal release from titanium fixtures during placement in the mandible: an experimental study. | |
| US6183255B1 (en) | Titanium material implants | |
| Nguyen et al. | The effect of sol–gel-formed calcium phosphate coatings on bone ingrowth and osteoconductivity of porous-surfaced Ti alloy implants | |
| Alves et al. | Tribocorrosion behavior of calcium-and phosphorous-enriched titanium oxide films and study of osteoblast interactions for dental implants | |
| Coelho et al. | Basic research methods and current trends of dental implant surfaces | |
| von Wilmowsky et al. | Implants in bone: Part I. A current overview about tissue response, surface modifications and future perspectives | |
| SE513481C3 (sv) | Implantatelement utfört av titan med en titanoxidyta modifierad med eloxidering | |
| Xue et al. | In vivo evaluation of plasma-sprayed titanium coating after alkali modification | |
| US20050031663A1 (en) | Implant element | |
| EP2178467B1 (en) | A bone tissue implant comprising lithium ions and method for manufacturing thereof | |
| Yeo | Dental implants: enhancing biological response through surface modifications | |
| Suh et al. | Effects of a novel calcium titanate coating on the osseointegration of blasted endosseous implants in rabbit tibiae | |
| Lim et al. | Initial contact angle measurements on variously treated dental/medical titanium materials | |
| He et al. | Early bone response to sandblasted, dual acid-etched and H2O2/HCl treated titanium implants: an experimental study in the rabbit | |
| Park et al. | Enhanced osteoconductivity of micro‐structured titanium implants (XiVE S CELLplus™) by addition of surface calcium chemistry: a histomorphometric study in the rabbit femur | |
| Roehling et al. | Sandblasted and acid-etched implant surfaces with or without high surface free energy: Experimental and clinical background | |
| Göransson et al. | Bone formation after 4 weeks around blood-plasma-modified titanium implants with varying surface topographies: an in vivo study | |
| Oshima et al. | Effect of Nanofeatured Topography on Ceria-Stabilized Zirconia/Alumina Nanocomposite on Osteogenesis and Osseointegration. | |
| Mei et al. | Effects of biomineralization on osseointegration of pure titanium implants in the mandible of beagles | |
| Guler et al. | The chemical surface evaluation of black and white porous titanium granules and different commercial dental implants with energy‐dispersive x‐ray spectroscopy analysis | |
| Giavaresi et al. | A novel multiphase anodic spark deposition coating for the improvement of orthopedic implant osseointegration: an experimental study in cortical bone of sheep | |
| Pak et al. | A histomorphometric study of dental implants with different surface characteristics | |
| Tatia et al. | Comparative Analysis of the Surface Properties of Different Dental Implants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| FZDE | Discontinued |